Infective Endocarditis Among Persons Aged 18–64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007−2017
Open Access
- 9 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (10), 1767-1781
- https://doi.org/10.1093/cid/ciaa372
Abstract
Background Infective endocarditis (IE) is a life-threatening bacterial infection of the heart valves, most often diagnosed in older persons and persons with prior cardiac surgery. It is also associated with injection drug use, a behavior that has increased in recent years along with the US opioid crisis. Methods We conducted a retrospective cohort analysis of commercial and Medicaid health insurance databases to estimate incident cases of IE in the United States in 2017, stratified by persons living with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and opioid use disorder (OUD). We also estimated annual percentage changes (EAPCs) in IE from 2007–2017 among persons with commercial insurance. Results The weighted incidence rate of IE was 13.8 cases per 100 000 persons among persons with commercial insurance, and 78.7 among those with Medicaid. The incidence rate of IE among commercially insured persons increased slightly from 2007–2017 (EAPC, 1.0%). It decreased among commercially insured persons living with HIV, from 148.0 in 2007 to 112.1 in 2017 (EAPC, −4.3%), and increased among those with HCV infection, from 172.4 in 2007 to 238.6 in 2017 (EAPC, 3.2%). Among persons aged 18–29 years with HCV infection, IE increased from 322.3 in 2007 to 1007.1 in 2017 (EAPC, 16.3%), and among those with OUD it increased from 156.4 in 2007 to 642.9 in 2017 (EAPC, 14.8%). Conclusions The incidence rate of IE increased markedly among young persons with HCV infections or OUD. This increase appears to parallel the ongoing national opioid crisis. Harm reduction with syringe services programs, medications for opioid use disorder, and safe injection practices can prevent the spread of HIV, HCV, and IE.Keywords
This publication has 34 references indexed in Scilit:
- Infective Endocarditis in the U.S., 1998–2009: A Nationwide StudyPLOS ONE, 2013
- Benefits of concurrent syringe exchange and substance abuse treatment participationJournal of Substance Abuse Treatment, 2011
- Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and ReinfectionThe Journal of Infectious Diseases, 2009
- Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and PlaceAmerican Journal of Epidemiology, 2008
- A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virusDrug and Alcohol Dependence, 2008
- Incidence of, Risk Factors for, Clinical Presentation, and 1-Year Outcomes of Infective Endocarditis in an Urban HIV CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users: A Comprehensive Review of the International EvidenceSubstance Use & Misuse, 2006
- Injection drug use and right sided endocarditisHeart, 2003
- Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and RisksThe Journal of Infectious Diseases, 2002
- Trends in crime and the introduction of a needle exchange programAmerican Journal of Public Health, 2000